Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

p53 gene mutation in B-cell chronic lymphocytic leukemia is associated with drug resistance and is independent of MDR1/MDR3 gene expression.

Blood - 1 Dec 1993

el Rouby S, Thomas A, Costin D, Rosenberg C R, Potmesil M, Silber R, Newcomb E W

Abstract excerpt

We studied 53 patients with B-cell chronic lymphocytic leukemia (B-CLL) and found mutations of the p53 gene in 15%. Patients with p53 gene mutations were found to have an aggressive form of B-CLL disease characterized by advanced Rai stage, rapid lymphocyte doubling time (LDT), and resistance to chemotherapy. While 27 of 29 treated patients (93%) without p53 mutations achieved a partial remission, only one of...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Aged
Share to Aged, 80 and over
Share to Base Sequence

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Drug Resistance

Share to Gene Expression

Share to Genes, p53

Share to Molecular Sequence Data

Share to Mutation

Source

Identifiers

PMID: 8241511

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

p53 gene mutation in B-cell chronic lymphocytic leukemia is associated with drug resistance and is independent of MDR1/MDR3 gene expression.PMID 8241511Read ↗

Multidrug resistance phenotype in patients with chronic lymphocytic leukemia as detected by immunofluorescence (FACS) and northern blot analysis.Semantic proximity Read ↗

MDR-1, but not MDR-3 gene expression, is associated with unmutated IgVH genes and poor prognosis chromosomal aberrations in chronic lymphocytic leukemia.Semantic proximity Read ↗

Mutation of p53 and consecutive selective drug resistance in B-CLL occurs as a consequence of prior DNA-damaging chemotherapy.Semantic proximity Read ↗

Cancer chemoresistance: The relationship between p53 and multidrug transportersSemantic proximity Read ↗

The tumor suppressor axis p53/miR-34a regulates Axl expression in B-cell chronic lymphocytic leukemia: implications for therapy in p53-defective CLL patientsSemantic proximity Read ↗

Coexpression of p53 protein and MDR functional phenotype in leukemias: the predominant association in chronic myeloid leukemia.Semantic proximity Read ↗

Mutations of the p53 gene as a prognostic factor in aggressive B-cell lymphoma.Semantic proximity Read ↗

Quantitative analysis of MDR1 (multidrug resistance) gene expression in human tumors by polymerase chain reaction.Semantic proximity Read ↗

p53-dependent regulation of <i>MDR1</i> gene expression causes selective resistance to chemotherapeutic agentsSemantic proximity Read ↗

[Multidrug resistance in chronic lymphocytic leukemia].Semantic proximity Read ↗

Aberrantly Activated APOBEC3B Is Associated With Mutant p53-Driven Refractory/Relapsed Diffuse Large B-Cell Lymphoma.Semantic proximity Read ↗

High dose methylprednisolone can induce remissions in CLL patients with p53 abnormalities.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.